Australia markets close in 2 hours 37 minutes

IGM Biosciences, Inc. (IGMS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
7.41-0.72 (-8.86%)
At close: 04:00PM EDT
7.41 0.00 (0.00%)
After hours: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 435.61M
Enterprise value 138.44M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)181.99
Price/book (mrq)2.14
Enterprise value/revenue 64.99
Enterprise value/EBITDA -0.54

Trading information

Stock price history

Beta (5Y monthly) 0.25
52-week change 3-34.42%
S&P500 52-week change 321.23%
52-week high 317.70
52-week low 33.81
50-day moving average 311.26
200-day moving average 38.60

Share statistics

Avg vol (3-month) 3261.48k
Avg vol (10-day) 3221.19k
Shares outstanding 533.29M
Implied shares outstanding 658.79M
Float 811.65M
% held by insiders 135.23%
% held by institutions 168.13%
Shares short (28 Mar 2024) 45.22M
Short ratio (28 Mar 2024) 420.23
Short % of float (28 Mar 2024) 433.52%
Short % of shares outstanding (28 Mar 2024) 48.88%
Shares short (prior month 29 Feb 2024) 44.51M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-9,722.43%

Management effectiveness

Return on assets (ttm)-34.91%
Return on equity (ttm)-100.48%

Income statement

Revenue (ttm)2.13M
Revenue per share (ttm)0.04
Quarterly revenue growth (yoy)75.00%
Gross profit (ttm)N/A
EBITDA -253.36M
Net income avi to common (ttm)-246.42M
Diluted EPS (ttm)-4.71
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)337.68M
Total cash per share (mrq)5.74
Total debt (mrq)40.51M
Total debt/equity (mrq)19.93%
Current ratio (mrq)8.18
Book value per share (mrq)3.46

Cash flow statement

Operating cash flow (ttm)-192.23M
Levered free cash flow (ttm)-121.96M